RU2017101410A3 - - Google Patents

Download PDF

Info

Publication number
RU2017101410A3
RU2017101410A3 RU2017101410A RU2017101410A RU2017101410A3 RU 2017101410 A3 RU2017101410 A3 RU 2017101410A3 RU 2017101410 A RU2017101410 A RU 2017101410A RU 2017101410 A RU2017101410 A RU 2017101410A RU 2017101410 A3 RU2017101410 A3 RU 2017101410A3
Authority
RU
Russia
Application number
RU2017101410A
Other languages
Russian (ru)
Other versions
RU2721401C2 (en
RU2017101410A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2017101410A publication Critical patent/RU2017101410A/en
Publication of RU2017101410A3 publication Critical patent/RU2017101410A3/ru
Application granted granted Critical
Publication of RU2721401C2 publication Critical patent/RU2721401C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2017101410A 2014-06-23 2015-06-23 Methods of treating or relieving migraine RU2721401C2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462015727P 2014-06-23 2014-06-23
US62/015,727 2014-06-23
US201562109386P 2015-01-29 2015-01-29
US62/109,386 2015-01-29
PCT/US2015/037177 WO2015200322A1 (en) 2014-06-23 2015-06-23 Methods of treating or ameliorating migraine

Publications (3)

Publication Number Publication Date
RU2017101410A RU2017101410A (en) 2018-07-24
RU2017101410A3 true RU2017101410A3 (en) 2019-01-21
RU2721401C2 RU2721401C2 (en) 2020-05-19

Family

ID=54938737

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017101410A RU2721401C2 (en) 2014-06-23 2015-06-23 Methods of treating or relieving migraine

Country Status (10)

Country Link
EP (1) EP3157943A4 (en)
JP (2) JP6688748B2 (en)
KR (1) KR20170018072A (en)
CN (1) CN106661085A (en)
AU (1) AU2015280108B2 (en)
BR (1) BR112016030375A8 (en)
CA (1) CA2953170A1 (en)
MX (1) MX2016017388A (en)
RU (1) RU2721401C2 (en)
WO (1) WO2015200322A1 (en)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006468A1 (en) * 1993-09-01 1995-03-09 Smithkline Beecham Corporation Method for treating migraine headaches
DE60131033T2 (en) * 2000-08-25 2008-07-17 Research Corp. Technologies, Inc., Tucson Uses of anticonvulsant amino acid for the treatment of bipolar disorders
EP1337559A2 (en) * 2000-11-17 2003-08-27 Bayer Ag Regulation of human nmda receptor
ES2381091T3 (en) * 2003-03-06 2012-05-23 Botulinum Toxin Research Associates, Inc. Treatment of chronic facial pain and headache related to sinusitis with botulinum toxin
WO2010010908A1 (en) * 2008-07-23 2010-01-28 協和発酵キリン株式会社 Therapeutic agent for migraine
WO2011003064A2 (en) * 2009-07-02 2011-01-06 Naurex, Inc. Methods of treating neuropathic pain
PL2985032T3 (en) * 2009-10-05 2019-07-31 Northwestern University Glyx for use in the treatment of alzheimer's disease, parkinson's disease or huntington's disease
US8951968B2 (en) * 2009-10-05 2015-02-10 Northwestern University Methods of treating depression and other related diseases
BR112012020142A2 (en) * 2010-02-11 2020-08-18 Northwestern University nmda receptor modulators with stabilized secondary structure and their uses.
EA201790653A1 (en) * 2011-04-27 2017-07-31 Нортвестерн Юниверсити METHOD OF TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISORDERS
WO2014059326A2 (en) * 2012-10-12 2014-04-17 Northwestern University Methods of identifying compounds for treating depression and other related diseases

Also Published As

Publication number Publication date
BR112016030375A8 (en) 2021-07-13
EP3157943A1 (en) 2017-04-26
CA2953170A1 (en) 2015-12-30
CN106661085A (en) 2017-05-10
RU2721401C2 (en) 2020-05-19
RU2017101410A (en) 2018-07-24
KR20170018072A (en) 2017-02-15
AU2015280108B2 (en) 2019-11-28
JP2017519778A (en) 2017-07-20
JP6688748B2 (en) 2020-04-28
EP3157943A4 (en) 2018-01-24
AU2015280108A1 (en) 2017-01-19
JP2020114863A (en) 2020-07-30
BR112016030375A2 (en) 2017-08-15
WO2015200322A1 (en) 2015-12-30
MX2016017388A (en) 2018-02-19

Similar Documents

Publication Publication Date Title
BR112016020776A2 (en)
BR112016027525A2 (en)
BR112016021201A2 (en)
BR112016018633A2 (en)
BR112016027506A2 (en)
BR112016018868A2 (en)
BR112016020142A2 (en)
BR112016017201A2 (en)
BR112016016546A2 (en)
BR112016026300A2 (en)
BR112016026807A2 (en)
BR112016016689A2 (en)
BR112016021197A2 (en)
BR112016023487A2 (en)
BR112016020096A2 (en)
BR112016020291A2 (en)
BR112016017226A2 (en)
BR112016019099A2 (en)
BR112016019970A2 (en)
BR112016022105A2 (en)
BR112016027088A2 (en)
BR112016022869A2 (en)
BR112016018965A2 (en)
BR112016018830A2 (en)
BR112016020091A2 (en)